SEC Form 4 · accession 0001683168-18-001536
Dougherty's Pharmacy, Inc. · MYDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Leslie
Officer — CEO, Interim Pres., Int. CFO · Director
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 3:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080029
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 23, 2018 | M | 5,200 | — | A | 1,668,453 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3,F4 | — | May 23, 2018 | M | 5,200 | D | — | — | Common Stock | 5,200 | 25,150 | D |
Explanation of responses
- F1Acquired pursuant to automatic vesting of Restricted Stock Units issued under the Issuer's Restricted Share Unit Incentive Plan.
- F2Issued under the Issuer's Restricted Share Unit Incentive Plan.
- F3Converted pursuant to automatic vesting of Restricted Stock Units issued under the Issuer's Restricted Share Unit Incentive Plan.
- F4Restricted Stock Units vest periodically through January 1, 2019.